SCHEMBL7744180

SCHEMBL7744180

O=C(CCCCl)Nc1oc(-c2cncc(-c3ccsc3)c2)nc1-c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.72
CYP2A6 P11509 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
CHEK2 O96017 1/20 0.38
CNR1 P21554 1/20 0.37
TRPM4 Q8TD43 1/20 0.37
ADORA1 P30542 2/20 0.35
ADORA2A P29274 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
RAB9A P51151 2/20 0.35
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982226 0.74 KDR (0.49) KDRFLT1FLT4ADORA1ALDH1A1
SCHEMBL7739081 0.72 KDR (0.63) KDRCYP2A6CHEK2ADORA1ADORA2A
SCHEMBL14148546 0.72 KDR (0.63) KDRFLT1FLT4CNR1ALDH1A1
SCHEMBL7744076 0.70 KDR (0.46) KDRFLT1FLT4ADORA1ADORA2A
SCHEMBL7744109 0.65 KDR (0.54) KDRCYP2A6FLT1FLT4CHEK2
SCHEMBL14148645 0.65 KDR (0.58) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744659 0.65 KDR (0.50) KDRFLT1FLT4ADORA1ALDH1A1
SCHEMBL7746647 0.65 KDR (0.41) KDRFLT1FLT4ADORA1ADORA2A
SCHEMBL7746658 0.64 KDR (0.55) KDRFLT1FLT4ADORA1ADORA2A
SCHEMBL7739022 0.64 KDR (0.54) KDRFLT1FLT4ADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed